Recent cases highlight patients' struggles with insurance denials, emphasizing the need for better patient advocacy.
Insurance Denials and Patient Advocacy
A recent case involving patient Patricia Herres highlights the ongoing challenges patients face with insurance coverage for necessary medical treatments. Herres, a 34-year-old from Texas, described experiencing repeated denials from her insurer, Anthem, despite the company having previously approved the medication. "They just started denying me over and over," she said. "I almost ran out of medication."
Company’s Initial Response and Future Implications
Anthem spokesperson DuBois confirmed that the company had initially approved the medication. However, the company's decision to deny coverage again, citing an unspecified treatment history, left Herres and her family feeling frustrated. "Are they going to deny other things, too?" Herres questioned. "I hope I don't have to keep fighting like this for the rest of my life."
Case of Anna Hocum: A Persistent Struggle
Similarly, 25-year-old Anna Hocum, from Milwaukee, has faced repeated denials from her insurer for treatment related to a rare genetic condition. "I just thought I was going to die," Hocum recounted. "I was fighting to survive, and then I was fighting to convince someone that I deserved to survive." Herocum's parents and friends and family stepped in, raising over $30,000 through a GoFundMe campaign to help cover costs. Despite the initial denial, the insurer eventually reversed its decision, but the approval was for only 12 months, leaving Hocum worried about future denials.
Ekirch's Battle and Family's Struggle
In a similar scenario, Jocelyn Ekirch, a 25-year-old from Texas, has been fighting Anthem for coverage of IVIG (intravenous immunoglobulin), a treatment essential for her autoimmune disease. Her mother, Lisa, recounted, "Even though it's a huge relief that Anthem is now obligated to cover Jocelyn's treatment, we don't know if or how we'll recoup the money already paid." The letter from Anthem stated that the authorization would be valid for a year starting on September 25, 2025.
Future Uncertainty and Patient Advocacy
Ekirch's access to IVIG may be in jeopardy again as her COBRA coverage through Anthem expires in late March. In April, she will need to transition to a new insurance plan, and she is bracing herself for another round of prior authorization. "I just am so afraid that I don't have the strength to go through and do what it takes," Ekirch said, "to fight this battle again."
Patient Stories and Advocacy
KFF Health News is actively seeking patient stories to inform their coverage. If you have an experience with prior authorization you'd like to share, you can submit your story [here](#).
Conclusion
These cases illustrate the persistent challenges patients face in securing essential medications and treatments. The experiences of Herres, Hocum, and Ekirch highlight the need for more transparent and consistent policies in insurance coverage.
Source: Read Original Article
Post a Comment